Opportunities for Healthy Volunteers

Contribute to medical research by participating in studies designed for healthy participants in your selected area.

↓

Matched clinical trials

  • A study to test if BHV-8000 is effective and safe for adults with early Parkinson’s disease

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Belgium Czechia France Germany Italy +4
  • Study of serotonin system changes in early Parkinson’s disease using [11C]DASB and [11C]SB207145 PET imaging in people with SNCA gene mutations

    Not yet recruiting

    4 1 1
    Investigated Diseases:
    France
  • Study on the Safety and Effects of LY3884961 for Patients with Parkinson’s Disease and a GBA1 Mutation

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    The Netherlands
  • Study of [18F]MC225 to Assess P-glycoprotein Function in Patients with Alzheimer’s, Mild Cognitive Impairment, and Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Drugs:
    The Netherlands
  • Study on the Effect of Clozapine on Immune Response in Patients with Parkinson’s Disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    France
  • Safety Study of Afamelanotide for Patients with Early Parkinson’s Disease

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    Investigated Drugs:
    Italy
  • Safety and Tolerability of NT-0796, Nadroparin, and Lidocaine Hydrochloride in Healthy Volunteers and Patients with Parkinson’s Disease

    Not recruiting

    1 1 1 1
    The Netherlands
  • Comparative Bioavailability of Inhaled Levodopa (Levodopa Cyclops) versus Inhaled Levodopa Powder with Carbidopa in Healthy Adults for Parkinson’s Disease

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria
  • Study of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson’s disease and motor fluctuations

    Not recruiting

    3 1 1 1
    Italy Poland Spain
  • Comparing Skin Adhesiveness of a New Rotigotine 12 mg/24 h Transdermal Patch Versus Standard Treatment in Patients with Parkinson’s Disease

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Germany